Skip to main content

Manel Mendoza Cobaleda

I am an Obstetrics and Gynecology specialist, responsible of the Placental Insufficiency Unit where we monitor pregnancies with preeclampsia or fetal growth restriction. In addition, I am investigator of the research group of Maternal-Fetal Medicine at the Vall d'Hebron Research Institute (VHIR) and associated clinical professor at the Universitat Autònoma de Barcelona.

Institutions of which they are part

Main researcher
Maternal and Fetal Medicine
Vall Hebron Institut de Recerca

Manel Mendoza Cobaleda

Institutions of which they are part

Main researcher
Maternal and Fetal Medicine
Vall Hebron Institut de Recerca

I am an Obstetrics and Gynecology specialist, responsible of the Placental Insufficiency Unit where we monitor pregnancies with preeclampsia or fetal growth restriction. In addition, I am investigator of the research group of Maternal-Fetal Medicine at the Vall d'Hebron Research Institute (VHIR) and associated clinical professor at the Universitat Autònoma de Barcelona.

I began my studies in Medicine at the Universitat Autònoma de Barcelona (UAB) and through the MIR I obtained the specialty in Obstetrics and Gynecology at the Vall d'Hebron University Hospital. Since 2017, I am responsible of the Placental Insufficiency Unit of the Vall d'Hebron Hospital, although since 2015 I have been part of it. Previously I had been researcher in the Preterm Prevention Unit where I was able to collaborate on several research projects. During 2013-2014 I had a training stay at the CHU Brugmann in Brussels to complement the training in this field. The work done in preventing preterm birth with cervical pessaries led to the completion of the doctoral thesis at the UAB. Since 2013, I have collaborated as a teacher in the various Maternal-Fetal Medicine courses organized by the Obstetrics service of the Vall d'Hebron Hospital, including the biannual course of Placental Insufficiency. Since 2017 I am a member of the Maternal and Fetal Medicine section of the Catalan Society of Obstetrics and Gynecology where we work to improve the maternal and fetal health of pregnant women.

Projects

Factores angiogénicos durante la gestación y riesgo cardiovascular a medio-largo plazo en las pacientes con preeclampsia. Abordaje clínico y experimental.

IP: Jaume Alijotas Reig
Collaborators: Manel Mendoza Cobaleda, Josep Perapoch López
Funding agency: Instituto de Salud Carlos III
Funding: 71995
Reference: PI16/01997
Duration: 01/01/2017 - 31/12/2019

Incorporación del ratio sFlt1/PlGF en el diagnóstico y clasificación de preeclampsia: Ensayo clínico randomizado (EuroPE estudio)

IP: Elisa Llurba Olivé
Collaborators: Jaume Alijotas Reig, Manel Mendoza Cobaleda
Funding agency: Instituto de Salud Carlos III
Funding: 111925
Reference: PI16/00375
Duration: 01/01/2017 - 13/06/2017

Related news

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

A study led by Dr. Manel Mendoza from Vall d’Hebron shows that studying the levels of placental markers is as effective as Doppler ultrasounds, the standard method for classifying the risk of pregnancies with low birth weight fetuses.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Meritxell Boada Perez

Meritxell Boada Perez

Predoctoral researcher
Pneumology
Read more
Marc-Enric Fernandez Exposito

Marc-Enric Fernandez Exposito

Tècnic/a Grau Superior
Unitat legal
Legal Directorate
Read more
Lluis Gabalda Martinez

Lluis Gabalda Martinez

Research technician
Molecular Medical Imaging
Read more
Betina Biagetti Biagetti

Betina Biagetti Biagetti

Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.